Trial Information

Summary: Patients with Mild to Moderate Alzheimer's Disease who are APO-E4 non-carriers.

We are currently recruiting patients with mild to moderate Alzheimer's Disease for a Clinical trail involving a study drug called Bapineuzumab. Bapineuzuab has not yet been approved by the FDA.

Subjects will be asked to participate in the study for aproximately 18 months, with 15 study visits during that time. Subjects must have a caregiver who can accompany them to all study visits.

Patient Inclusion Criteria

  • Male or Female age 50<89
  • Diagnosis of probably Alzheimer's Disease
  • Has a caregiver who can visits with the subject at least 5 days per week and would be willing accompany them to the study site and for all study visits.
  • Willing to undergo ApoE testing and agree to disclosure of the results.
  • Non-carrier of the ApoE4 allele according to genetic tests.

PatientExclusionCriteria

  • ApoE4 carrier
  • Does not have a caregiver who can accompany the subject to the study site and for all study visits.

    • Primary Outcomes
    To demonstrate and advantage of th efficacy of multiple doses of IV administered bapineuzumab in patients with mild to moderate AD over placebo.

    Key Secondary Outcomes
    To demonstrate an advantage of the effect of multiple doses of IV administered bapineuzumab in patients with mild to moderate AD over placebo on additional cognitive and global measures.

    Contact:

    Jodi Larkin, Clinical Research Coordinator
    Neurocare, Inc.
    70 Wells Avenue
    Newton, MA 02459
    Telephone: 617-581-6416
    Email:

    Profile Page: Neurocare, Inc., Newton, MA

    If you would like to learn more about participating in this study, please send an e-mail message using the form below.

    *Subject:

    Name:

    Address:

    City:

    State:

    *Zip:

    *Country:

    Phone:

    *Email address:

    Message:

    Please note: A number of commercial online services display an error message after you click on Send. Please be assured that your message has been received.

    This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

    Trial listings updated: September 3, 2008 at 2:53:46 PM


Back to Centerwatch Trial Listing by Location


Additional resources
in this illness area

Copyright © 1995 - 2008, CenterWatch
All Rights Reserved

This site was developed in association with Illumina Interactive, Boston, MA